Ondansetron Injection Franchise in Ahmedabad

Antiemetic Injection Supplier in Mumbai

Nausea & Vomiting Medicine Distributor in Delhi

Antiemetic Pharma Franchise in Bangalore

Ondansetron Injection Stockist in Hyderabad
Antiemetic Injection Manufacturer & Exporter in Chandigarh

Home/Products /ondansetron-10mg-injection

Ondotyle 10 Injection

Composition : Ondansetron (10mg) Injection

Dosage Form : Injection

Packaging Type : Ampule

Packaging : 5x2ml

Price : ₹0/-

Please Contact For Best Price

Ondotyle 10 Injection contains Ondansetron 10mg, a selective serotonin (5-HT3) receptor antagonist used for effective control of nausea and vomiting. It works by blocking serotonin receptors involved in triggering the vomiting reflex, ensuring reliable symptom control.

This injection is widely administered in chemotherapy-induced nausea, radiotherapy-associated vomiting, and postoperative nausea, making it an essential supportive therapy in hospital and clinical settings.

For franchise partners, Ondotyle 10 Injection represents a high-rotation product in the antiemetic segment, driven by consistent hospital demand and routine use across oncology and surgical care. Its strong prescriber acceptance supports steady secondary sales.

With increasing emphasis on supportive care medicines, Ondotyle 10 Injection offers stable business growth opportunities, helping partners strengthen their injectable portfolio in the antiemetic therapy segment.


Read More

About the Product

Ondotyle 10 Injection contains Ondansetron 10mg, a selective serotonin (5-HT3) receptor antagonist used for effective control of nausea and vomiting. It works by blocking serotonin receptors involved in triggering the vomiting reflex, ensuring reliable symptom control.

This injection is widely administered in chemotherapy-induced nausea, radiotherapy-associated vomiting, and postoperative nausea, making it an essential supportive therapy in hospital and clinical settings.

For franchise partners, Ondotyle 10 Injection represents a high-rotation product in the antiemetic segment, driven by consistent hospital demand and routine use across oncology and surgical care. Its strong prescriber acceptance supports steady secondary sales.

With increasing emphasis on supportive care medicines, Ondotyle 10 Injection offers stable business growth opportunities, helping partners strengthen their injectable portfolio in the antiemetic therapy segment.


Ondotyle 10 Injection is indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative conditions. It is also useful in managing severe vomiting of various causes when oral therapy is not feasible.

Ondotyle 10 Injection is indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative conditions. It is also useful in managing severe vomiting of various causes when oral therapy is not feasible.

Ondotyle 10 Injection should be administered under medical supervision. Caution is advised in patients with cardiac disorders, electrolyte imbalance, or liver impairment. It should be used carefully in patients receiving other medicines that may prolong the QT interval.

Store Ondotyle 10 Injection in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children and do not use after the expiry date printed on the ampoule.

Get in Touch